Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 Dec;26(12):1306–1311. doi: 10.1136/gut.26.12.1306

Circulating human leucocyte elastase in patients with inflammatory bowel disease.

E O Adeyemi, S Neumann, V S Chadwick, H J Hodgson, M B Pepys
PMCID: PMC1433115  PMID: 3853525

Abstract

The plasma concentration of human leucocyte elastase (HLE), measured by enzyme immunoassay as the complex with alpha 1-proteinase inhibitor, was determined in 94 patients with active and inactive inflammatory bowel disease. In Crohn's disease and in ulcerative colitis human leucocyte elastase levels were raised significantly above normal when the disease was active, and fell on remission. The mean human leucocyte elastase level in 31 cases of active Crohn's disease was significantly greater than the mean human leucocyte elastase level in 23 patients with active ulcerative colitis (p = 0.013). The values of human leucocyte elastase correlated significantly with Crohn's disease activity index scores (p = 0.05) and with the circulating concentration of C-reactive protein (p less than 0.05 and p less than 0.01 for ulcerative colitis and Crohn's disease respectively), but not with the erythrocyte sedimentation rate. These results indicate that the concentration of human leucocyte elastase in the plasma of patients with inflammatory bowel disease reflects the activity of their intestinal disease and suggest that serial measurements of human leucocyte elastase may be useful in the assessment and clinical management of these conditions.

Full text

PDF
1306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Best W. R., Becktel J. M., Singleton J. W. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979 Oct;77(4 Pt 2):843–846. [PubMed] [Google Scholar]
  2. Cooke W. T., Prior P. Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol. 1984 Feb;6(1):17–25. [PubMed] [Google Scholar]
  3. De Dombal F. T., Burton I. L., Clamp S. E., Goligher J. C. Short-term course and prognosis of Crohn's disease. Gut. 1974 Jun;15(6):435–443. doi: 10.1136/gut.15.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dronfield M. W., Langman M. J. Serum lysozyme in inflammatory bowel disease. Gut. 1975 Dec;16(12):985–987. doi: 10.1136/gut.16.12.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Egbring R., Schmidt W., Fuchs G., Havemann K. Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects. Blood. 1977 Feb;49(2):219–231. [PubMed] [Google Scholar]
  6. Fagan E. A., Dyck R. F., Maton P. N., Hodgson H. J., Chadwick V. S., Petrie A., Pepys M. B. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest. 1982 Aug;12(4):351–359. doi: 10.1111/j.1365-2362.1982.tb02244.x. [DOI] [PubMed] [Google Scholar]
  7. Falchuk K. R., Perrotto J. L., Isselbacher K. J. Serum lysozyme in Crohn's disease and ulcerative colitis. N Engl J Med. 1975 Feb 20;292(8):395–397. doi: 10.1056/NEJM197502202920805. [DOI] [PubMed] [Google Scholar]
  8. Falchuk K. R., Perrotto J. L., Isselbacher K. J. Serum lysozyme in Crohn's disease. A useful index of disease activity. Gastroenterology. 1975 Oct;69(4):893–896. [PubMed] [Google Scholar]
  9. Gramse M., Bingenheimer C., Schmidt W., Egbring R., Havemann K. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro. J Clin Invest. 1978 Apr;61(4):1027–1033. doi: 10.1172/JCI109001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Janoff A. Human granulocyte elastase. Further delineation of its role in connective tissue damage. Am J Pathol. 1972 Sep;68(3):579–592. [PMC free article] [PubMed] [Google Scholar]
  11. Johnson U., Ohlsson K., Olsson I. Effects of granulocyte neutral proteases on complement components. Scand J Immunol. 1976;5(4):421–426. doi: 10.1111/j.1365-3083.1976.tb00296.x. [DOI] [PubMed] [Google Scholar]
  12. Kane S. P., Vincenti A. C. Mucosal enzymes in human inflammatory bowel disease with reference to neutrophil granulocytes as mediators of tissue injury. Clin Sci (Lond) 1979 Oct;57(4):295–303. doi: 10.1042/cs0570295. [DOI] [PubMed] [Google Scholar]
  13. Klass H. J., Neale G. Serum and faecal lysozyme in inflammatory bowel disease. Gut. 1978 Mar;19(3):233–239. doi: 10.1136/gut.19.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LOCKHART-MUMMERY H. E., MORSON B. C. CROHN'S DISEASE OF THE LARGE INTESTINE. Gut. 1964 Dec;5:493–509. doi: 10.1136/gut.5.6.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOCKHART-MUMMERY H. E., MORSON B. C. Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut. 1960 Jun;1:87–105. doi: 10.1136/gut.1.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mallas E., Terry J. M., Asquith P., Cooke W. T. Serum lysozyme in inflammatory bowel and coeliac disease. J Clin Pathol. 1976 Jul;29(7):598–600. doi: 10.1136/jcp.29.7.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Morson B. C. Rectal biopsy in inflammatory bowel disease. N Engl J Med. 1972 Dec 28;287(26):1337–1339. doi: 10.1056/NEJM197212282872607. [DOI] [PubMed] [Google Scholar]
  18. O'Morain C., Smethurst P., Levi A. J., Peters T. J. Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease. J Clin Pathol. 1983 Nov;36(11):1312–1316. doi: 10.1136/jcp.36.11.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Plow E. F., Edgington T. S. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest. 1975 Jul;56(1):30–38. doi: 10.1172/JCI108076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Saverymuttu S. H., Peters A. M., Lavender J. P., Pepys M. B., Hodgson H. J., Chadwick V. S. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology. 1983 Dec;85(6):1333–1339. [PubMed] [Google Scholar]
  21. Shine B., de Beer F. C., Pepys M. B. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 1981 Nov 25;117(1):13–23. doi: 10.1016/0009-8981(81)90005-x. [DOI] [PubMed] [Google Scholar]
  22. TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Virca G. D., Mallya R. K., Pepys M. B., Schnebli H. P. Quantitation of human leukocyte elastase, cathepsin G, alpha-2-macroglobulin and alpha-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids. Adv Exp Med Biol. 1984;167:345–353. doi: 10.1007/978-1-4615-9355-3_29. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES